BusinessAlembic Pharma Q4 PAT Rises 29% to Rs 203 Crore
Alembic Pharmaceuticals' consolidated net profit increased by 29.19% to Rs 202.70 crore in Q4 FY26, up from Rs 156.89 crore in Q4 FY25. The company's stock rose 1.11% to Rs 795.20 following the earnings report.
Business Standard·


